Skip to main contentSkip to navigation
Sirius Investors

COR Stock: Cencora, Inc. Stock Price, Analysis & Insights

Get live COR stock price $281.43, comprehensive Cencora, Inc. stock analysis, charts, news, and expert forecast. Real-time COR stock data and investment insights.

281.43
0.67%Today
CORCencora, Inc. • New York Stock Exchange • Healthcare
Market Cap
54.76B
Volume
237.50K
52W High
377.54
52W Low
244.82

Loading chart data...

Cencora, Inc. (COR) Overview

Cencora, Inc. (COR) is a publicly traded company in the Healthcare sector , specifically within the Medical - Distribution industry . As of the latest trading session, COR trades at $281.43 with a market capitalization of 54.76B . Over the past 52 weeks, COR has traded between $244.82 and $377.54 , with the current price positioned at approximately 28% of this range . The stock currently trades...

Key Takeaways

  • Operates in the Healthcare sector (Medical - Distribution)
  • Market cap: 54.76B
  • Current price: $281.43
  • 52-week range: $244.82 - $377.54
  • P/E ratio: 21.58

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a br...

Company Information

CEO
Robert Mauch
Sector
Healthcare
Industry
Medical - Distribution
Employees
47000

Contact Information

Address
1 West First Avenue
Country
US

Investment Analysis & Business Insights

Healthcare
Medical - Distribution

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 21.6)

Lower volatility stock (Beta: 0.59) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Cencora, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Cencora, Inc.
  • Investors should consider how Cencora, Inc. fits within their overall portfolio allocation

Market Cap

54.76B

P/E Ratio (TTM)

21.58

Beta

0.59

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.